Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Janssen Biotech
Pharma
J&J makes its case for Tremfya in two IBD indications
Tremfya's prospects in inflammatory bowel disease look bright, thanks to the drug's first efficacy data in UC and long-term results in Crohn's.
Fraiser Kansteiner
Feb 18, 2022 10:30am
J&J's Blue Jacket Fashion Show returns live
Feb 15, 2022 7:25am
For pharma sales reps dealing with HCPs, the future is digital
Dec 8, 2021 7:15am
Aspen trumpets its "game changer" licensing pact-to-be with J&J
Dec 2, 2021 9:30am
Further growth coming for J&J's manufacturing site in Ireland
Sep 13, 2021 9:28am
J&J taps Twitter to expand its network of patient storytellers
Jul 20, 2021 11:29am
